Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer.

Zhang D, Hu Q, Liu X, Ji Y, Chao HP, Liu Y, Tracz A, Kirk J, Buonamici S, Zhu P, Wang J, Liu S, Tang DG
Nat Commun. 2020 Apr 29;11(1):2089. doi: 10.1038/s41467-020-15815-7. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.